Medicare Enrolled
Dr. Rajiv Agarwal, MD
Cardiac Rehabilitation Registered Nurse · Humble, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Agarwal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Agarwal? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Agarwal
Dr. Rajiv Agarwal is a cardiac rehabilitation registered nurse in Humble, TX, with 18 years in practice. Based on federal Medicare data, Dr. Agarwal performed 49,949 Medicare services across 8,946 unique beneficiaries.
Between the years covered by Open Payments, Dr. Agarwal received a total of $21,930 from 51 pharmaceutical and/or device companies across 793 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiac rehabilitation registered nurse. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Agarwal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 50% volume in TX$ $21,930 industry payments
Medicare Practice Summary
Medicare Utilization ↗49,949
Medicare services
Top 50% in TX for cardiac rehabilitation registered nurse
8,946
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,775 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging, lower concentration | 20,100 | $0 | $2 |
| Contrast dye for imaging (iodine-based) | 15,820 | $0 | $2 |
| Regadenoson injection (Lexiscan) for heart stress test | 2,924 | $43 | $550 |
| Office visit, established patient (30-39 min) | 2,371 | $95 | $340 |
| Electrocardiogram (EKG), 12-lead | 1,238 | $11 | $55 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 741 | $52 | $390 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 741 | $624 | $1,610 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 719 | $1,959 | $7,176 |
| Nuclear medicine study of heart muscle blood flow by pet | 719 | $147 | $749 |
| External counterpulsation, per treatment session | 379 | $85 | $320 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 344 | $678 | $2,191 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 321 | $21 | $85 |
| Injection of drug or substance into vein | 321 | $30 | $125 |
| Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | 301 | $98 | $337 |
| New patient office visit (45-59 min) | 274 | $114 | $516 |
| Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session | 270 | $98 | $337 |
| Ultrasound of both sides of head and neck blood flow | 239 | $131 | $627 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 208 | $126 | $610 |
| Echocardiogram, transthoracic | 185 | $129 | $650 |
| Ultrasound of leg arteries or artery grafts | 174 | $180 | $795 |
| Hospital follow-up visit, moderate complexity | 156 | $65 | $231 |
| Office visit, established patient (20-29 min) | 151 | $70 | $235 |
| Ct scan of blood vessels and grafts of heart with contrast | 129 | $232 | $1,120 |
| Home visit, established patient, low complexity | 100 | $61 | $262 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 86 | $93 | $380 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 81 | $1,364 | $5,962 |
| Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | 76 | $1,072 | $4,740 |
| Ct scan of blood vessels of chest with contrast | 75 | $162 | $845 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 73 | $317 | $1,260 |
| Ct scan of abdominal aorta and both leg arteries with contrast | 73 | $230 | $930 |
| EKG interpretation and report | 71 | $7 | $30 |
| Ct scan of blood vessels of neck with contrast | 54 | $206 | $830 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 53 | $201 | $865 |
| Programming of dual lead pacemaker system | 45 | $54 | $214 |
| Remote pacemaker/defibrillator monitoring, 90 days | 36 | $14 | $80 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 36 | $25 | $95 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 33 | $171 | $1,003 |
| Initial hospital admission, moderate complexity | 31 | $107 | $462 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 26 | $873 | $4,291 |
| Remote pacemaker monitoring, 90 days | 26 | $17 | $100 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 24 | $78 | $188 |
| Residence visit for new patient with low level of medical decision making, per day, if using time, at least 30 minutes | 23 | $60 | $245 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 21 | $300 | $1,485 |
| CT scan of chest, without contrast | 19 | $106 | $495 |
| Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | 16 | $100 | $404 |
| Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 16 | $82 | $419 |
| Ct scan of heart structure with contrast | 15 | $173 | $775 |
| Home visit, established patient, moderate complexity | 15 | $102 | $401 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
85.6% medium
13.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,930
Total received (2018-2024)
Avg $3,133/year across 7 years
1.0× state median for specialty
51
Companies
793
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,985 (77.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,900 (22.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$45 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,867
2023$3,090
2022$3,688
2021$2,055
2020$1,209
2019$1,940
2018$7,080
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Relypsa, Inc.
$5,397
Boston Scientific Corporation
$2,069
Novartis Pharmaceuticals Corporation
$1,760
Janssen Pharmaceuticals, Inc
$1,305
Abbott Laboratories
$1,283
Amgen Inc.
$905
Boehringer Ingelheim Pharmaceuticals, Inc.
$805
Impulse Dynamics (USA) Inc.
$732
Merck Sharp & Dohme LLC
$656
BOSTON SCIENTIFIC CORPORATION
$484
AstraZeneca Pharmaceuticals LP
$468
Novo Nordisk Inc
$424
PFIZER INC.
$403
E.R. Squibb & Sons, L.L.C.
$386
SANOFI-AVENTIS U.S. LLC
$347
BIOTRONIK INC.
$319
Astellas Pharma US Inc
$318
Amarin Pharma Inc.
$291
Kowa Pharmaceuticals America, Inc.
$285
Esperion Therapeutics, Inc.
$281
Alnylam Pharmaceuticals Inc.
$260
Actelion Pharmaceuticals US, Inc.
$251
Medtronic, Inc.
$249
Medtronic Vascular, Inc.
$246
Lexicon Pharmaceuticals, Inc.
$233
Tactile Systems Technology Inc
$218
Siemens Medical Solutions USA, Inc.
$216
Biosense Webster, Inc.
$178
Regeneron Healthcare Solutions, Inc.
$176
CVRx, Inc.
$156
HeartFlow, Inc.
$99
AngioDynamics, Inc.
$95
Merck Sharp & Dohme Corporation
$88
Inspire Medical Systems, Inc.
$62
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$62
Althera Pharmaceuticals LLC
$55
Bardy Diagnostics, Inc.
$50
Stability Biologics, LLC
$47
Bard Peripheral Vascular, Inc.
$40
ARBOR PHARMACEUTICALS, INC.
$39
Bayer Healthcare Pharmaceuticals Inc.
$36
G Medical Diagnostic Services, Inc.
$23
Medline Industries LP
$22
Itamar Medical Inc
$20
Aziyo Biologics, Inc.
$20
SCPHARMACEUTICALS INC.
$15
PORTOLA PHARMACEUTICALS, INC.
$15
Arbor Pharmaceuticals, Inc.
$14
Gilead Sciences, Inc.
$12
Allergan Inc.
$12
ZOLL Circulation Inc
$6
Top 3 companies account for 42.1% of total payments
Associated products mentioned in payments ›
AMVUTTRA · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · Amplia MRI · Artis Q biplane · BELSOMRA · BEVYXXA · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · BodyGuardian · CAMZYOS · CARDIOMEMS · CARTO 3 · CHANTIX · CONFIRM RX · COREVALVE EVOLUT R · CROSSER · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Carto 3 · Cios Alpha · ClosureFast · Confirm Rx · Connectivity and Remote care · Corlanor · ECM · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · Ensite Cardiac Mapping System · FARXIGA · FFRct · FLEXITOUCH · FUROSCIX · Flexitouch Plus · GENERAL - VASCULAR INTERVENTION · General - Stents · HARMONY · HeartMate 3 Left Ventricular Assist Device · HeartMate Touch · INSPIRE · Inpefa · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LUTONIX · LUX DX · LifeVest · Livalo · MERLIN@HOME · MICRA · MITRACLIP · MULTAQ · Merlin Connectivity and Remote · Micra · MitraClip System · NEXLETOL · NEXLIZET · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · Optimizer · Orsiro Mission · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROCLAIM · Pacemakers · RESONATE · RESONATE EL ICD VR · Repatha · Reveal LINQ · Roszet · Rybelsus · Symmetry · Temperature Management System · UPTRAVI · VENASEAL · VERQUVO · VIGILANT · Varithena Administration Pack · Vascepa · Veltassa · VenaSeal · ViewFlex Xtra ICE Catheter · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WatchPATONE · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (77%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $44 per 100 Medicare services performed
Geographic Context
Cardiac Rehabilitation Registered Nurses within 10 mi
1
Per 100K population
0.0
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN NORTHEAST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Agarwal is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Agarwal experienced with contrast dye for imaging, lower concentration?
Based on Medicare claims data, Dr. Agarwal performed 20,100 contrast dye for imaging, lower concentration services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Agarwal receive payments from pharmaceutical companies?
Yes. Dr. Agarwal received a total of $21,930 from 51 companies across 793 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Agarwal's costs compare to other cardiac rehabilitation registered nurses in Humble?
Dr. Agarwal's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Agarwal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiac Rehabilitation Registered Nurses in Humble
Browse cardiac rehabilitation registered nurses in Humble ranked by procedure volume and transparency data.
Highest volume
Top Cardiac Rehabilitation Registered Nurses in TX
Cardiac Rehabilitation Registered Nurses ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiac Rehabilitation Registered Nurses in TX
Which TX cardiac rehabilitation registered nurses receive the most from drug and device companies.
By company
Relypsa, Inc. Payments to Doctors
See all physicians who received payments from Relypsa, Inc..
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology